We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Arterial Disease Risk Score Predicts Cardiovascular Events

By HospiMedica International staff writers
Posted on 04 Jun 2013
A new study describes a prediction model to aid doctors in more accurately determining the risk cardiovascular disease (CVD) patients face for developing a new event.

Researchers at University Medical Center (UMC; Utrecht, The Netherlands), Erasmus Medical Center (Rotterdam, The Netherlandsl), and other institutions, conducted a study involving 5,788 patients referred with various clinical manifestations of arterial disease between January 1996 and February 2010. More...
The data were used for the development and validation of stratification and prediction models of recurrent event risk based on vascular risk factors, imaging, or both. In all, 788 recurrent vascular events—such as myocardial infarction (MI), stroke, or vascular death—were observed during a mean 4.7 years of follow-up.

The end result was a Secondary Manifestations of ARTerial disease (SMART) model for prediction of 10-year recurrent vascular event risk, based on age and sex, in addition to clinical parameters that included medical history, current smoking, systolic blood pressure, and laboratory biomarkers. By using the clinical parameters alone model—without imaging or ultrasound data—there was less than 20% risk in 59% of patients, 20%–30% risk in 19%, and over 30% risk in 23%. The study was published online first on April 10, 2013, in Heart.


“Up to now, we put all patients with vascular disease in one and the same high-risk group, even if we knew from daily practice that there is an enormous variation in the risk between patients,” said study coauthor Prof. Frank Visseren, MD, a UMC specialist in internal and vascular medicine. “Some patients have a high risk while many others have only a low or normal risk of a recurring cardiovascular event; but until recently we were not able to differentiate between them. By using the SMART risk score that is now possible, which means that we can give better treatment advice to patients.”

Related Links:

University Medical Center
Erasmus Medical Center




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.